News

Christophe Weber joined Takeda in April 2014 as chief operating officer. He was named president and representative director in June 2014, and subsequently appointed CEO in April 2015.
Takeda Pharmaceutical Co Ltd (NYSE: TAK) Q1 2022 Earnings Conference Call July 30, 2021 6:00 AM ET Company Participants Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber ...
When Christophe Weber was appointed CEO of Takeda in 2014, he set out on a mission to transform the 240-year old Japanese pharmaceutical company into a major global player.
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2022 Earnings Conference Call October 28, 2021 5:30 AM ETCompany ParticipantsChristopher O’Reilly - ...
Pressure to reduce medicine prices swirls in US, Europe ‘You cannot just close the eyes and squeeze the price’: Weber Christophe Weber on Oct. 31.Photographer: Kiyoshi Ota/Bloomberg Gift this ...
Takeda Pharmaceutical Co. ’s shares might be trading at about half of their level before the $62 billion acquisition of Shire in 2018, but the drug pipeline and cash management are helping to ...
Takeda Pharmaceutical Company Limited (TKPYY) Proposed Acquisition of Shire PLC Group May 8, 2018 3:15 AM ET Executives Christophe Weber - President and CEO Costa Saroukos - CFO Chris Morabito - R ...
Takeda Pharmaceutical Co Ltd (NYSE: TAK) Q2 2021 Earnings Conference Call October 29, 2020 5:30 AM ET Company Participants Christopher O'Reilly - IR Christophe Weber - President, CEO ...
Takeda Pharmaceutical Company Limited (NYSE: TAK) Q1 2022 Results Conference Call July 28, 2022 6:00 AM ET Company Participants Ayako Iwamuro - IR Christophe Weber - President and CEO Andy Plump ...
Takeda Pharmaceutical Company Limited. (NYSE: TAK) Q3 2022 Earnings Conference Call February 3, 2022 6:00 AM ET Corporate Participants Christopher O’Reilly - Global Head, IR & Global Finance ...
Takeda Pharmaceutical Co Ltd (NYSE: TAK) Q3 2021 Earnings Conference Call February 4, 2021 6:00 AM ET Company Participants Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber ...